Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Expleo Solutions Limited, encompassing its various subsidiaries, specializes in providing global software validation and verification services, primarily catering to the banking, financial services, and insurance industries. The company's comprehensive suite of services includes quality engineering, quality management, robust software testing, DevOps implementation, and test automation. Established in 1998 and headquartered in Chennai, India, the firm operated under the name SQS India BFSI Limited until its rebranding to Expleo Solutions Limited in April 2019. Expleo Solutions Limited is a subsidiary of Expleo Technology Germany GmbH.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.
Target Price
The average target price of EXPLEOSOL.NS is 1140 and suggests 33.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation